Stents

BEST trial, ACC.15,

Despite the advent of a new generation of stents, patients with multiple narrowed arteries in the heart who received coronary artery bypass grafting fared better than those whose arteries were opened with balloon angioplasty and stents in a study...

Cardinal Health announced plans to acquire Johnson & Johnson’s Cordis business, a leading global manufacturer of cardiology and endovascular devices, for $1.94 billion in cash. 

Patients who took dual antiplatelet therapy medications beyond the standard 12 months after coronary stent placement were significantly less likely to develop blood clots within their stents or to have a heart attack than those whose treatment fol...

October 8, 2014 — Abbott announced the start of the ABSORB IV clinical trial, which will test whether the Absorb bioresorbable vascular scaffold (BVS) is more cost effective and offers a higher quality of life than a best-in-class, permanent,...

Boston Scientific, Eluvia, MAJESTIC trial, vascular stent, PAD
A key trial evaluating the Boston Scientific Eluvia drug-eluting vascular stent system met its primary endpoint, with more than 94 percent of the lesions...
carotid artery stenting, F-EPD, P-EPD, ACC, embolic protection devices
A study published in JACC: Cardiovascular Interventions showed that in-hospital and 30-day stroke or death rates were equally low with either a distal filter...
BEST Trial
Despite the advent of a new generation of stents, patients with multiple narrowed arteries in the heart who received coronary artery bypass grafting fared...
Medtronic, Drug Filled Stent, clinical trial, ACC
Medtronic plc unveiled the preclinical outcomes of its novel Drug-Filled Stent (DFS) at the 64th Annual Scientific Session of the American College of...
The Abbott family of Xience everolimus-eluting coronary stents—including the Xience V, Xience nano, Xience Prime, Xience Xpedition, and
MicroVention Inc.’s Low-Profile Visualized Intraluminal Support Device (LVIS and LVIS Jr.) is a stent and delivery system used to...
Boston Scientific received U.S. Food and Drug Administration (FDA) approval for the Rebel platinum chromium coronary stent system, the...

Articles

BEST Trial
Despite the advent of a new generation of stents, patients with multiple narrowed arteries in the heart who received coronary artery bypass grafting fared...
Medtronic, Drug Filled Stent, clinical trial, ACC
Medtronic plc unveiled the preclinical outcomes of its novel Drug-Filled Stent (DFS) at the 64th Annual Scientific Session of the American College of...
Tryton Side Branch Stent, Pivotal IDE, bifurcation stent, bifurcation stent
Tryton Medical Inc. announced that results from the company’s pivotal clinical trial for the Tryton Side Branch Stent were published in the Journal of the...
A study being presented at the Society of Interventional Radiology’s annual scientific meeting says 3-D printing could become a powerful tool in customizing...

Video Center

U.S. healthcare reform is largely being driven through adoption of new information technology (IT...
1 week 6 days ago
The biggest technology news coming out of the 2015 American College of Cardiology (ACC) annual...
5 weeks 6 days ago
It’s been no secret that the American healthcare system needed to change to survive economically...
11 weeks 6 days ago
Centricity, webinar, ZFV, ZFP, viewer, remote viewing system, enterprise
Healthcare organizations are demanding more capabilities for image viewers accessed by clinicians. Zero footprint (ZFP) viewers provide imaging tools from...
The webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" educates participants about the state of the art clinical and emerging translational...
This webinar discusses why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient and...